Fundz

Kyttaro Ltd reported raising $2.09 Million in an initial SEC Form D filing, from an offering of $2.09 Million

PRIVATEDec 22, 2022Late filing, first sale May 28, 2021

Amount Raised

$2.09 Million

$2.09 Million sold, per SEC Form D (first sale May 28, 2021)

Round Type

Seed

United KingdomBiotechnology

Who to call at Kyttaro Ltd, and when

A new round usually means Kyttaro Ltd is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Kyttaro Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kyttaro Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kyttaro Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kyttaro Ltd

Location

C/O HILLIER HOPKINS LLP

United Kingdom

About

Kyttaro Therapeutics was incorporated in the US in 2021 to commercialize technologies developed by the founders of Apceth Biopharma GmbH since 2007. The company is headquartered in New York, with research operations in Germany. Kyttaro Therapeutics is a development-stage platform technology company with a unique patent portfolio in clinical applications of mesenchymal stem cells (MSCs) for treatment of diseases with a high, unmet clinical need. Kyttaro’s expertise and intellectual property are based on 15 years of research and development in Germany and around the world in cutting-edge applications for MSC Alpha-1 Antitrypsin (MSC-AAT), MSC Cytokines (MSC-Cyt) and MSC-Klotho.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kyttaro Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Kyttaro Ltd's next move

See what Strategic adds

Kyttaro Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.